Magnesium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520sulphate

# Magnesium Sulfate ## Overview Magnesium sulfate is an essential mineral that plays a crucial role in numerous biochemical functions, including neuromuscular transmission, muscle contraction, cardiac function, and enzyme activity. ## Primary Indications * **Hypomagnesemia:** Treatment and prevention of low serum magnesium levels. * **Eclampsia/Preeclampsia:** Prevention and management of seizures associated with severe preeclampsia and eclampsia. * **Torsades de Pointes:** Treatment of polymorphic ventricular tachycardia, particularly when associated with a prolonged QT interval. * **Bronchodilation:** Adjunctive therapy in severe, acute asthma exacerbations (less common, evidence is mixed). * **Cardiac Arrhythmias:** Management of certain arrhythmias refractory to standard therapy. ## Adult Dosing **Hypomagnesemia:** * **Mild Deficiency (serum Mg < 1.5 mEq/L):** 2-4 grams IV in divided doses over 12-24 hours, followed by maintenance therapy (e.g., 4-6 grams orally or 2-4 grams IV every 12-24 hours). * **Severe Deficiency (serum Mg < 1 mEq/L):** 4-6 grams IV initially, followed by 1-2 grams IV per hour until serum magnesium is corrected or symptoms resolve. * **Maximum Infusion Rate:** Generally, do not exceed 8 grams in 24 hours for IV replacement unless carefully monitored. For severe deficiency, infusion rates up to 2 grams/hour may be used cautiously. **Eclampsia/Preeclampsia:** * **Loading Dose:** 4-6 grams IV over 5-10 minutes. * **Maintenance Dose:** 2 grams IV per hour by continuous infusion. Some protocols may use 1 gram IV per hour, or intramuscular (IM) doses of 5 grams in each buttock every 4 hours. Local protocol dictates precise regimen. * **Maximum Dose:** Generally not to exceed 40 grams in 24 hours. **Torsades de Pointes:** * **Acute Infusion:** 1-2 grams IV in 10-20 mL D5W over 5-10 minutes, followed by a continuous infusion of 0.5-1 gram/hour. Higher doses may be required. **Bronchodilation (Adjunctive):** * **Infusion:** 1-2 grams IV in 50-100 mL normal saline or D5W over 15-30 minutes. ## Pediatric Dosing Dosing in pediatric patients requires careful calculation based on weight and clinical indication. Dosing is often guided by institutional protocols. **Hypomagnesemia (Repletion):** * **Intravenous:** 25-50 mg/kg/dose (elemental magnesium) IV over 1-4 hours. Maximum dose typically 2 grams elemental magnesium. * **Intramuscular:** 25-50 mg/kg/dose (elemental magnesium) IM every 4-6 hours. **Eclampsia/Preeclampsia:** * Dosing is typically based on adult protocols, but may be adjusted for weight. Common regimens involve a loading dose of 40 mg/kg (elemental magnesium) IV (max 4 grams) followed by a maintenance infusion of 20 mg/kg/hour (max 1 gram/hour). ## Dose Adjustments * **Renal Impairment:** Magnesium is renally excreted. Use with caution in patients with impaired renal function. Reduce dose and monitor serum magnesium levels closely. In severe renal impairment, the drug may need to be avoided. ## Contraindications * Myocardial damage. * Heart block. * Hypermagnesemia. * Hypersensitivity to magnesium sulfate. * Hypercalciuria (calcium stones). ## Adverse Effects * **Common:** Flushing, warmth, hypotension, nausea, vomiting, diaphoresis, decreased reflexes, sedation. * **Serious:** Respiratory depression, cardiac arrhythmias, cardiac arrest, hypermagnesemia (symptoms include hyporeflexia, muscle weakness, confusion, lethargy, respiratory depression, hypotension, cardiac arrest). ## Key Drug Interactions * **Neuromuscular Blocking Agents:** May potentiate neuromuscular blockade. * **Calcium Channel Blockers:** Additive hypotensive effects and potential for excessive neuromuscular blockade. * **Tetracyclines/Quinolones:** Magnesium sulfate may decrease the absorption of oral tetracyclines and fluoroquinolones; administer these drugs at least 2 hours before or 4-6 hours after magnesium. ## Monitoring * **Serum Magnesium Levels:** Crucial, especially with IV infusions or in patients with renal impairment. Target levels vary by indication. * **Renal Function:** Monitor BUN and creatinine. * **Deep Tendon Reflexes:** Loss of reflexes is an early sign of hypermagnesemia. * **Respiratory Rate and Depth:** Monitor for respiratory depression. * **Blood Pressure and Heart Rate:** Monitor for hypotension and bradycardia. * **Urine Output:** Important indicator of renal function and magnesium excretion. ## Clinical Pearls * Magnesium sulfate is available in various concentrations; verify the concentration before administration. * Rapid IV infusion can cause hypotension and dangerous cardiac effects. Administer IV infusions slowly and with continuous monitoring. * Intramuscular injections can be painful; consider administering into larger muscle groups and with lidocaine if protocols allow. * In patients with normal renal function, magnesium toxicity is uncommon with standard therapeutic doses. * Always consider the elemental magnesium content when calculating doses. Typical conversion: 1 gram Magnesium Sulfate (MgSO4) ≈ 0.12 grams (or 120 mg) elemental magnesium (Mg2+). *** **Disclaimer:** This information is intended for educational purposes and should not replace current, official prescribing information, local institutional protocols, or clinical judgment. Always verify drug information with up-to-date resources before administration.